Heartflow, a cardiac CT AI vendor, files for a $100 million IPO after notable adoption and revenue growth.
Key Details
- 1Heartflow filed SEC documents for a $100M IPO following positive coverage news for its AI CT software.
- 2Radiology benefits manager EviCore and proposed Medicare Fee Schedule support are expected to boost future adoption.
- 3Heartflow's CT-based platform has been used on over 400,000 patients, including 132,000 last year.
- 4Company reported $126 million in revenue for 2023, up 44% year-over-year, but posted a $32.3 million quarterly loss in early 2024.
- 5Market opportunity for Heartflow's AI solutions estimated at $5 billion in the U.S. annually.
- 6IPO proceeds will be used for debt payment, sales, R&D, and general operations.
Why It Matters
Heartflow's IPO marks a major milestone in the maturation of radiology-focused AI companies and demonstrates growing clinical and payer acceptance of imaging AI tools. The public funding and Medicare consideration signal greater integration of AI in CT-based cardiovascular diagnostics.
Source
Radiology Business
Related News
•AuntMinnie
Deep Learning AI Outperforms Radiologists in Detecting ENE on CT
A deep learning tool, DeepENE, exceeded radiologist performance in identifying lymph node extranodal extension in head and neck cancers using preoperative CT scans.
•AuntMinnie
XGBoost Outperforms Logistic Regression for Lung Cancer Risk Prediction
XGBoost-based lung cancer risk prediction model shows greater accuracy than logistic regression in a large screening cohort.
•Radiology Business
Imaging AI Systems Could Play Key Role in Future Pandemic Response
A study finds that repurposed AI detection tools in radiology could help address future pandemics more effectively.